z-logo
open-access-imgOpen Access
In vitro activity of isavuconazole against Trichosporon, Rhodotorula, Geotrichum, Saccharomyces and Pichia species
Author(s) -
George R. Thompson,
Nathan P. Wiederhold,
D.A. Sutton,
Annette W. Fothergill,
Thomas F. Patterson
Publication year - 2009
Publication title -
journal of antimicrobial chemotherapy
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 2.124
H-Index - 194
eISSN - 1460-2091
pISSN - 0305-7453
DOI - 10.1093/jac/dkp138
Subject(s) - voriconazole , posaconazole , rhodotorula , flucytosine , trichosporon , fluconazole , microbiology and biotechnology , geotrichum , biology , amphotericin b , yeast , candida krusei , antifungal , biochemistry
The emergence of less common, but clinically important, fungal pathogens including the rare yeasts has contributed to the substantial morbidity and mortality observed in immunocompromised patients. These organisms can be resistant or refractory to existing antifungal agents. We sought to evaluate the activity of the new triazole isavuconazole against these difficult pathogens.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here
Accelerating Research

Address

John Eccles House
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom